Home > Healthcare > Medical Devices > Therapeutic Devices > Continence Care Market

Continence Care Market Size

Report ID: GMI3535
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

Continence Care Market Size

Continence Care Market size was worth more than USD 14 billion in 2021 and it is expected to grow at a CAGR of over 7% through 2030. Supportive reimbursement initiatives and advancements in healthcare systems are driving global market growth.

Continence Care Market

To get key market trends

Download Free Sample

The burgeoning adoption of continence care products along with the advancements in healthcare services is slated to amplify the revenue inflows of this industry in the ensuing years. Technical upgradations pertaining to the identification and treatment of chronic renal ailments as well as increasing awareness of incontinence diseases are further boosting product demand.

A number of federal initiatives backed by both government and non-government organizations, as well as the favorable reimbursement policies, encourage the use of continence care products and related therapies. A wide range of both private and public insurers, as well as international healthcare organizations support the adoption of continence care products through reimbursement initiatives. For instance, Medicare and Medicaid in the US compensate for around 120 and 200 catheters per person each month, respectively.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global continence care market was valued over USD 14 billion in 2021 and is anticipated to expand at a CAGR of over 7% through 2030, driven by growing health consciousness among individuals.

The urinary catheter market segment held a sizable market share in 2021 and is projected to be valued at approximately USD 3 billion by 2030 owing to its increasing usage resulting from the rising prevalence of chronic urinary ailments and other health disorders.

The market growth is anticipated to be driven by the growing comorbidities linked with rising health concerns among the female population due to various medical conditions. The feminine health disease segment is estimated to witness a CAGR of more than 7% CAGR over 2022-2030.

The key companies in the continence care industry include Essity AB, Kimberly-Clark Corporation, Coloplast, Unicharm Corporation, Paul Hartmann AG, Ontex, First Quality Enterprises, Medline Industries Inc., Hollister Incorporated, ConvaTec Group PLC, B. Braun Melsungen AG, ABENA A/S, Attends Healthcare Products, Inc., Becton Dickinson and Company, Urocare Products, Inc., Cardinal Health, Fu Burg Industrial Co. Ltd., MRK Healthcare Pvt. Ltd. (Nulife), Principle Business Enterprises, Inc. and others.